zip >>> 02142
sector >>> Healthcare
fullTimeEmployees >>> 7400
longBusinessSummary >>> Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases worldwide. The company offers TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for the treatment of spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an etanercept biosimilar referencing ENBREL; IMRALDI, an adalimumab biosimilar referencing HUMIRA; and FLIXABI, an infliximab biosimilar referencing REMICADE. In addition, the company offers RITUXAN for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL), rheumatoid arthritis, two forms of ANCA-associated vasculitis, and pemphigus vulgaris; RITUXAN HYCELA for non-Hodgkin's lymphoma and CLL; GAZYVA to treat CLL and follicular lymphoma; and OCREVUS for the treatment of relapsing MS and primary progressive MS; and other anti-CD20 therapies. Further, it is involved in developing Opicinumab, BIIB061, and BIIB091 for MS and neuroimmunology; Aducanumab, BAN2401, BIIB092, BIIB076, and BIIB080 to treat Alzheimer's disease and dementia; BIIB067, BIIB078, BIIB110, and BIIB100 to treat neuromuscular disorders; BIIB054 and BIIB094 for treating movement disorders; BIIB111 and BIIB112 for ophthalmology; Dapirolizumab pegol and BIIB059 to treat immunology and others; BIIB104 for neurocognitive disorders; BIIB093, TMS-007, and Natalizumab to treat acute neurology; BIIB074 and BIIB095 for pain; and SB11 biosimilar, which are under various stages of development. The company offers products through its sales force and marketing groups. Biogen Inc. has collaboration agreements with Genentech, Inc.; Ionis Pharmaceuticals, Inc.; Eisai Co., Ltd.; Alkermes Pharma Ireland Limited; Bristol-Myers Squibb Company; Acorda Therapeutics, Inc.; AbbVie Inc.; Skyhawk Therapeutics, Inc.; Neurimmune SubOne AG; and Sangamo Therapeutics Inc. The company was founded in 1978 and is headquartered in Cambridge, Massachusetts.
city >>> Cambridge
phone >>> 617 679 2000
state >>> MA
country >>> United States
companyOfficers >>> []
website >>> http://www.biogen.com
maxAge >>> 1
address1 >>> 225 Binney Street
industry >>> Drug Manufacturers—General
previousClose >>> 270.04
regularMarketOpen >>> 268.29
twoHundredDayAverage >>> 290.11
trailingAnnualDividendYield >>> None
payoutRatio >>> 0
volume24Hr >>> None
regularMarketDayHigh >>> 274.26
navPrice >>> None
averageDailyVolume10Day >>> 1329600
totalAssets >>> None
regularMarketPreviousClose >>> 270.04
fiftyDayAverage >>> 279.17737
trailingAnnualDividendRate >>> None
open >>> 268.29
toCurrency >>> None
averageVolume10days >>> 1329600
expireDate >>> None
yield >>> None
algorithm >>> None
dividendRate >>> None
exDividendDate >>> None
beta >>> 0.523411
circulatingSupply >>> None
startDate >>> None
regularMarketDayLow >>> 267.52
priceHint >>> 2
currency >>> USD
trailingPE >>> 8.027259
regularMarketVolume >>> 682873
lastMarket >>> None
maxSupply >>> None
openInterest >>> None
marketCap >>> 43263774720
volumeAllCurrencies >>> None
strikePrice >>> None
averageVolume >>> 1220617
priceToSalesTrailing12Months >>> 2.986324
dayLow >>> 267.52
ask >>> 277.99
ytdReturn >>> None
askSize >>> 800
volume >>> 682873
fiftyTwoWeekHigh >>> 374.99
forwardPE >>> 8.866969
fromCurrency >>> None
fiveYearAvgDividendYield >>> None
fiftyTwoWeekLow >>> 219.7
bid >>> 273
tradeable >>> False
dividendYield >>> None
bidSize >>> 900
dayHigh >>> 274.26
exchange >>> NMS
shortName >>> Biogen Inc.
longName >>> Biogen Inc.
exchangeTimezoneName >>> America/New_York
exchangeTimezoneShortName >>> EDT
isEsgPopulated >>> False
gmtOffSetMilliseconds >>> -14400000
quoteType >>> EQUITY
symbol >>> BIIB
messageBoardId >>> finmb_29726
market >>> us_market
annualHoldingsTurnover >>> None
enterpriseToRevenue >>> 6.214
beta3Year >>> None
profitMargins >>> 0.4091
enterpriseToEbitda >>> 11.188
52WeekChange >>> 0.17378223
morningStarRiskRating >>> None
forwardEps >>> 30.82
revenueQuarterlyGrowth >>> None
sharesOutstanding >>> 158312992
fundInceptionDate >>> None
annualReportExpenseRatio >>> None
bookValue >>> 71.438
sharesShort >>> 3312424
sharesPercentSharesOut >>> 0.0209
fundFamily >>> None
lastFiscalYearEnd >>> 1577750400
heldPercentInstitutions >>> 0.93154997
netIncomeToCommon >>> 5926799872
trailingEps >>> 34.044
lastDividendValue >>> None
SandP52WeekChange >>> 0.108078
priceToBook >>> 3.825415
heldPercentInsiders >>> 0.00657
nextFiscalYearEnd >>> 1640908800
mostRecentQuarter >>> 1593475200
shortRatio >>> 2.63
sharesShortPreviousMonthDate >>> 1596153600
floatShares >>> 314635359
enterpriseValue >>> 90019307520
threeYearAverageReturn >>> None
lastSplitDate >>> 979776000
lastSplitFactor >>> 3:1
legalType >>> None
morningStarOverallRating >>> None
earningsQuarterlyGrowth >>> 0.032
dateShortInterest >>> 1598832000
pegRatio >>> -2.65
lastCapGain >>> None
shortPercentOfFloat >>> 0.021
sharesShortPriorMonth >>> 2552327
category >>> None
fiveYearAverageReturn >>> None
regularMarketPrice >>> 268.29
logo_url >>> https://logo.clearbit.com/biogen.com
